MexicoMexico is Latin America's second-largest pharmaceutical market and a gateway to 130 million consumers. Taevas delivers end-to-end COFEPRIS navigation, distributor access, and commercial launch support so your brand captures revenue faster.
Select an industry to see regulatory pathways, services, and how Taevas supports your Mexico market entry.
Comision Federal para la Proteccion contra Riesgos Sanitarios (COFEPRIS)
Mexico's medical device market is valued at over $3 billion and is among the most dynamic in Latin America, driven by a growing middle class and expanding private healthcare infrastructure. All medical devices must be registered with COFEPRIS under a risk-based classification system (Class I through Class IV), with Class III and IV requiring full technical dossiers. Taevas provides comprehensive regulatory strategy, dossier preparation, and in-country representation to accelerate your device approval and commercial launch.
All medical devices sold in Mexico require a Registro Sanitario issued by COFEPRIS. Class I devices follow a simplified notification pathway, while Class II through IV require full technical dossiers including clinical and safety data.
COFEPRIS classifies devices from Class I (low risk) to Class IV (high risk) based on intended use and patient contact. Correct classification is critical as it determines the depth of documentation and review timeline required.
Foreign manufacturers must obtain an import licence from COFEPRIS before shipping medical devices into Mexico. Taevas manages the aviso de importacion process and coordinates with customs brokers to ensure compliant entry.
COFEPRIS requires ongoing vigilance reporting, including adverse event notifications and periodic safety updates for registered devices. Taevas maintains your compliance calendar and manages all post-market submissions on your behalf.
Taevas combines deep COFEPRIS regulatory expertise with an established commercial network across Mexico, giving life-sciences brands a single, accountable partner from registration to revenue.
Our Mexico team has hands-on experience navigating COFEPRIS registration pathways for medical devices, pharmaceuticals, cosmetics, and food supplements, reducing approval timelines and avoiding costly dossier rejections.
With operational bases in Mexico City, Monterrey, and Guadalajara, Taevas provides genuine on-the-ground support for regulatory meetings, distributor management, and KOL engagement across all 32 states.
Our pre-validated regulatory templates, established COFEPRIS relationships, and parallel-track submission strategy consistently shorten the path from first filing to product launch in Mexico.
Taevas maintains vetted relationships with leading Mexican distributors across public sector (IMSS, ISSSTE), private hospital networks, pharmacy chains, and specialist retail channels, removing the guesswork from partner selection.
We manage structured KOL programmes with leading Mexican physicians, pharmacists, and procurement specialists across therapeutic areas, building the clinical credibility your brand needs to win in Mexico's competitive market.
Taevas has supported life-sciences brands from the US, Europe, and Asia-Pacific in successfully entering Mexico and broader Latin American markets, with a portfolio spanning devices, pharmaceuticals, cosmetics, and supplements.
Book a free consultation with our Mexico team and receive a tailored regulatory and commercial roadmap for your product category, so you enter with confidence and launch without delay.